{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:46:33Z","timestamp":1794948393825,"version":"4.9.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3712-8","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T07:58:34Z","timestamp":1510041514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-1763","authenticated-orcid":false,"given":"Santino","family":"Minichillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cubelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Quercia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dall\u2019Olio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rapezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"issue":"2","key":"3712_CR1","first-page":"105","volume":"48","author":"T Marinko","year":"2014","unstructured":"Marinko T, Dolenc J. Bilban-Jakopin Cvetka. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radio. Oncologia. 2014;48(2):105\u201312.","journal-title":"Oncologia"},{"key":"3712_CR2","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2007.11.0106","volume":"25","author":"L Telli Melinda","year":"2007","unstructured":"Telli Melinda L, Hunt Sharon A, Carlson Robert W, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol. 2007;25:3525\u201333.","journal-title":"J Clin Oncol"},{"key":"3712_CR3","doi-asserted-by":"crossref","unstructured":"Keefe Deborah L. Trastuzumab-associated cardiotoxicity. CANCER October 1, 2002 \/ Volume 95 \/ Number 7.","DOI":"10.1002\/cncr.10854"},{"key":"3712_CR4","doi-asserted-by":"publisher","unstructured":"Mart\u00edn M, Esteva FJ, Alba E, Khandheria B, P\u00e9rez-Isla L, Garc\u00eda-S\u00e1enz JA, M\u00e1rquez A, Sengupta P, Zamorano J. Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations. Oncologist. 2009 Jan;14(1):1\u201311. doi: 10.1634\/theoncologist.2008-0137 . Epub 2009 Jan 15.","DOI":"10.1634\/theoncologist.2008-0137"},{"issue":"2","key":"3712_CR5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5114\/wo.2013.34624","volume":"17","author":"J Huzno","year":"2013","unstructured":"Huzno J, Les D, Sarzyczny-Slota D, Nowara E. Cardiac side effects of trastuzumab in breast cancer patients \u2013 single centers experiences. Wspolczesna Onkol. 2013;17(2):190\u20135.","journal-title":"Wspolczesna Onkol"},{"key":"3712_CR6","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.transproceed.2009.06.029","volume":"41","author":"E Castells","year":"2009","unstructured":"Castells E, Roca J, Miralles A, et al. Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain. Transplant Proc. 2009;41:2237\u20139.","journal-title":"Transplant Proc"},{"issue":"12","key":"3712_CR7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.mayocp.2014.08.011","volume":"89","author":"J Herrmann","year":"2014","unstructured":"Herrmann J, Herrmann SM, Haddad TC. New-onset heart failure in association with severe hypertension during trastuzumab therapy. Mayo Clin Proc. 2014;89(12):1734\u20139.","journal-title":"Mayo Clin Proc"},{"key":"3712_CR8","doi-asserted-by":"crossref","unstructured":"Martins JS, Dos Santos VM, Thommen Teles L, Alves Leite V. Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab. Rev Med Chile 2012; 140: 763\u2013766.","DOI":"10.4067\/S0034-98872012000600010"},{"key":"3712_CR9","first-page":"14","volume":"3","author":"JR Walker","year":"2009","unstructured":"Walker JR, Singal OK, Jassal DS. The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure. Exp Clin Cardiol Vol. 2009;3:14.","journal-title":"Exp Clin Cardiol Vol"},{"key":"3712_CR10","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1200\/JCO.2005.08.789","volume":"23","author":"JD Floyd","year":"2005","unstructured":"Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy. J Clin Oncol. 2005;23:7685\u201396.","journal-title":"J Clin Oncol"},{"key":"3712_CR11","doi-asserted-by":"crossref","unstructured":"Perik PJ, et al. Indium-111-labeled Trastuzumab Scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 24:2276\u201328.","DOI":"10.1200\/JCO.2005.03.8448"},{"key":"3712_CR12","doi-asserted-by":"publisher","unstructured":"Cardinale D, Colombo A, Torrisi R, Sandri MT, Civelli M, Salvatici M, Lamantia G, Colombo N, Cortinovis S, Dessanai MA, Nol\u00e8 F, Veglia F, Cipolla CM. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol. 2010 Sep 1;28(25):3910\u20133916. doi: 10.1200\/JCO.2009.27.3615 . Epub 2010 Aug 2.","DOI":"10.1200\/JCO.2009.27.3615"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T15:17:38Z","timestamp":1570288658000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3712-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3712"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3712-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,7]]},"article-number":"722"}}